Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Mohamed Ali Soussi"'
Autor:
Leila Achour, Chema Drira, Mohamed Zied Sboui, Ikram Fazaa, Mohamed Ali Soussi, Senda Hammami, Tarek Ben Othman, Myriam Razgallah Khrouf
Publikováno v:
Journal of Market Access & Health Policy, Vol 11, Iss 1 (2023)
ABSTRACTIntroduction: New procedures and diagnostic tests in hematopoietic stem cell transplantation (HSCT) are associated with a significant increase in costs. The last cost estimate of allogeneic HSCT done in Tunisia was in 1996 and concerned only
Externí odkaz:
https://doaj.org/article/3f944d1cc6814e7998184dbff1c45d3f
Autor:
Myriam Razgallah Khrouf, Leila Achour, Asma Thabti, Mohamed Ali Soussi, Nour Abdejelil, Olfa Lazreg, Chema Drira, Aida Zahaf, Saloua Ladab, Tarek Ben Othman
Publikováno v:
Journal of Market Access & Health Policy, Vol 5, Iss 1 (2017)
Background: Hematopoietic stem cell transplantation (HSCT) is a medically complicated therapy with a long recovery time. In Tunisia, the National Health Insurance Fund (CNAM) covers only the first year post-transplantation, after which the costs are
Externí odkaz:
https://doaj.org/article/bd1f0157bcfa4792a753ad867b6754ac
Autor:
Meriem Laribi, Radhwen Mhidi, Mohamed Ali Soussi, Mohamed Anouar Nouioui, Mohamed Lotfi Efrit
Publikováno v:
Chemistry Africa.
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 56:201-209
Summary Introduction Validate an analytical method for the determination of Sodium and Potassium in parenteral nutrition bags by indirect potentiometry using correction factors; and evaluate routine control results. Material and methods An analytical
Publikováno v:
Annales Pharmaceutiques Françaises. 79:266-274
The aim of this study is to validate a new HPLC-FIA method for routine analytical control of cyclosporine injectable preparations and to evaluate the routine analytical control with this technic.Cyclosporine dosage was carried out by the HPLC-FIA met
Autor:
Myriam Razgallah Khrouf, Chema Drira, Mohamed Ali Soussi, Wiem Ben Ayed, Hanen Ouesleti, Ines Fradi, Fathi Safta, Besma Hamdene
Publikováno v:
Journal of Oncology Pharmacy Practice. 27:827-833
Background Cytarabine is widely used to treat leukemia and lymphoma. Currently, Cyrabol®, powder for injection, is one of the specialties marketed in Tunisia. However, no stability data when diluted with 0.9% NaCl are available. The aim of this stud
Autor:
Myriam Hadoussa, Myriam Razgallah Khrouf, Mehdi Bouhlel, Selma Hadoussa, Chema Drira, Mohamed Ali Soussi
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 26(1)
Introduction Biosimilar drugs have significantly shaken the global pharmaceutical market through a better access to the health care services. The aim of this study is to establish a state of play in Tunisia based on the knowledge and perceptions of d
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522094713
Introduction In order to implement a centralized cytotoxic reconstitution unit (CCRU), a study was conducted to compare the implementation costs of a CCRU equipped with a cytotoxic safety cabinet (CSC) and one equipped with an isolator with negative
Autor:
Myriam Razgallah Khrouf, Habib Besbes, Selima Zaouali, Monia Ouederni, Fethi Mellouli, Manel Turki, Mohamed Bejaoui, Monia Ben Khaled, Mohamed Ali Soussi
Publikováno v:
Nutrition Clinique et Métabolisme. 29:159-162
Following a national out-of-stock of pharmaceutical speciality made with multivitamins formula for intravenous infusion, two hospitalized children with immuno-hematological disorder receiving vitamins-unsupplemented total parenteral nutrition (TPN),
Autor:
Mohamed Ali Soussi, Joëlle Dubois, Samir Messaoudi, Jérôme Bignon, Déborah Desravines, Olivier Provot, Mouad Alami, Jean-Daniel Brion, Guillaume Bernadat
Publikováno v:
ChemMedChem
ChemMedChem, Wiley-VCH Verlag, 2015, 10 (8), pp.1392-1402. ⟨10.1002/cmdc.201500069⟩
ChemMedChem, Wiley-VCH Verlag, 2015, 10 (8), pp.1392-1402. ⟨10.1002/cmdc.201500069⟩
A series of novel isocombretaquinazolines (isoCoQ) 4 were quickly prepared by coupling N-toluenesulfonylhydrazones with 4-chloroquinazolines under palladium catalysis. These compounds, which can be regarded as isocombretastatin A-4 (isoCA-4) analogue